Lifecore Biomedical, Inc. De (LFCR) Invested Capital (2011 - 2025)

Lifecore Biomedical's Invested Capital history runs 15 years deep, the most recent figure standing at $131.8 million for Q2 2025.

• In Q2 2025, Invested Capital fell 3.1% year-over-year to $131.8 million; the TTM figure through May 2025 stood at $131.8 million (down 3.1% YoY), while the FY2025 annual figure was $131.8 million, down 3.1% from the prior year.
• Invested Capital was $131.8 million for Q2 2025 at Lifecore Biomedical, up from $127.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $366.8 million in Q2 2021 to a low of $75.3 million in Q3 2023.
• Historically, Invested Capital has averaged $179.8 million across 5 years, with a median of $135.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Invested Capital plunged 57.34% in 2023, then surged 68.7% in 2024.
• A 5-year view of Invested Capital shows it stood at $279.6 million in 2021, then retreated by 21.99% to $218.1 million in 2022, then tumbled by 56.78% to $94.3 million in 2023, then jumped by 34.44% to $126.8 million in 2024, then rose by 3.96% to $131.8 million in 2025.
• The last three Invested Capital figures came in at $131.8 million (Q2 2025), $127.2 million (Q1 2025), and $126.8 million (Q4 2024), per Business Quant data.